Targeted News Service logo

-- Preview Email Newsletter
U.S. Congressional Tipoffs Involving Maryland Newsletter for 2026-07-22 ( 3 items )  
Congressman Mfume's Remarks at DOGE Subcommittee Hearing on American History and the Smithsonian (10)
WASHINGTON, July 21 -- Rep. Kweisi Mfume, D-Maryland, issued the following news release: * * * Congressman Mfume's Remarks at DOGE Subcommittee Hearing on American History and the Smithsonian * WASHINGTON, D.C. - Today, Congressman Rep. Kweisi Mfume spoke out against the Trump administration's attacks on Black history and on the Smithsonian Institution during a hearing on the House Oversight Committee's DOGE Subcommittee. In 2026, Congressman Mfume has consistently pushed back on the Trump administration's attempts to reshape the presenta more PR

Hoyer: We Cannot Turn the Clock Back to the Time Before the ADA (10)
WASHINGTON, July 21 -- Rep. Steny H. Hoyer, D-Maryland, issued the following news release: * * * Hoyer: We Cannot Turn the Clock Back to the Time Before the ADA * WASHINGTON, DC - Today, Congressman Steny H. Hoyer (MD-05) delivered remarks on the House Floor ahead of the 36th anniversary of the Americans with Disabilities Act (ADA) on Sunday, July 26th, 2026. Below are a video and transcription of his remarks:Click here to watch a video of his remarks. "Mr. Speaker, one of the proudest moments of my time in public service was sponsoring  more PR

McClain Delaney's Bipartisan SCALE Biology Act Advances Out of House Science, Space, and Technology Committee (10)
WASHINGTON, July 21 -- Rep. April McClain Delaney, D-Maryland, issued the following news release: * * * McClain Delaney's Bipartisan SCALE Biology Act Advances Out of House Science, Space, and Technology Committee * Washington, D.C. - Congresswoman April McClain Delaney's (D-MD-06) bipartisan Standards and Calibration for American Leadership in Engineering Biology (SCALE Biology) Act advanced this week out of the House Science, Space, and Technology Committee, marking a significant step forward in strengthening U.S. leadership in biotechnol more PR